Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

XERIS PHARMACEUTICALS INC (XERS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2021 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
10/05/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Amended and Restated Certificate of Incorporation of the Registrant",
"Amended and Restated Bylaws of the Registrant",
"Second Supplemental Indenture, by and among the Registrant, Xeris Biopharma Holdings, Inc. and U.S. Bank National Association",
"Joinder and Sixth Amendment to Amended and Restated Loan and Security Agreement, by and among the Registrant, Oxford Finance LLC and Silicon Valley Bank"
09/14/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
07/30/2021 8-K Quarterly results
07/28/2021 8-K Quarterly results
07/19/2021 8-K Quarterly results
06/08/2021 8-K Quarterly results
05/24/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
03/11/2021 8-K Quarterly results
03/09/2021 8-K Quarterly results
12/17/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/14/2020 8-K Other Events  Interactive Data
11/16/2020 8-K Unregistered Sales of Equity Securities, Financial Statements and Exhibits  Interactive Data
Docs: "FORM OF EXCHANGE AGREEMENT"
11/09/2020 8-K Quarterly results
Docs: "XERIS PHARMACEUTICALS REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS"
10/08/2020 8-K Quarterly results
08/20/2020 8-K Quarterly results
08/10/2020 8-K Quarterly results
07/01/2020 8-K Quarterly results
06/26/2020 8-K Quarterly results
06/04/2020 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/07/2020 8-K Quarterly results
04/24/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Amendment No. 1 to the Amended and Restated By-laws of Xeris Pharmaceuticals, Inc",
"U.S. Small Business Administration Paycheck Protection Program Note, entered into April 21, 2020 by the Company"
04/10/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Xeris Pharmaceuticals, Inc. Deferred Compensation Plan"
03/11/2020 8-K Quarterly results
02/13/2020 8-K Quarterly results
02/10/2020 8-K Quarterly results
11/07/2019 8-K Quarterly results
Docs: "XERIS PHARMACEUTICALS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS Assets Current assets: Cash and cash equivalents $ 56,160 $ 45,716"
10/01/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "XERIS PHARMACEUTICALS APPOINTS MARK THIERER TO BOARD OF DIRECTORS"
09/10/2019 8-K Quarterly results
08/06/2019 8-K Quarterly results
06/06/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Investor Contact"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy